Physician profile
John J Obrien
NPI 1255445862
$3,997.80
in general payments reported to CMS, 2019-2025
15 companies · $296 in 2025
The $296 reported for 2025 was less than what a typical Plastic Surgery Within The Head and Neck provider received nationally (typical 2025 total: $300).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $235 · 2021: $139 · 2022: $779 · 2023: $1,270 · 2024: $735 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,552 · Long Term Medical Supply Or Device Loan: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,552.08 |
| Long Term Medical Supply Or Device Loan | $748.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,328.53 | 2021-2025 | Integra, Durasorb Monofilament Mesh, Omnigraft |
| Merz North America, INC. | $1,056.01 | 2019-2023 | Xeomin |
| Mentor Worldwide LLC | $358.27 | 2022-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Tela Bio, INC. | $335.08 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Sientra, INC. | $226.80 | 2022 | |
| Abbvie INC. | $193.75 | 2023-2025 | |
| Smith+Nephew, INC. | $177.81 | 2022 | |
| Motiva USA, LLC | $139.32 | 2024-2025 | |
| Galderma Laboratories, L.P. | $47.06 | 2021-2024 | |
| Allergan, INC. | $31.45 | 2019-2020 | |
| Apyx Medical Corporation | $25.82 | 2019 | |
| Idorsia Pharmaceuticals US INC | $22.34 | 2023 | Quviviq |
| Pacira Pharmaceuticals Incorporated | $22.19 | 2023 | Exparel |
| Solta Medical, A Division of Bausch Health US, LLC | $20.01 | 2022 | |
| Abbott Laboratories | $13.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Obrien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.